|
JP2004284957A
|
|
Vascular smooth muscle cell proliferation inhibitor
|
|
JP2004041373A
|
|
Ozone generator fan
|
|
JP2004024174A
|
|
Diagnostic agent for schizophrenia
|
|
JP2003235959A
|
|
Method for eliminating or reducing c-type hepatitis virus
|
|
JP2003055230A
|
|
Prophylactic and therapeutic agent for colon cancer
|
|
JP2000095695A
|
|
Therapeutic agent for schizophrenia
|
|
JP2000262612A
|
|
Method for procedure of hiv infectious disease
|
|
JP2000191685A
|
|
Cholestanol compound and medicine containing the same
|
|
JP2000162210A
|
|
Diagnostic medicine for schizophrenia
|
|
JPH11196898A
|
|
Diagnostic medicine for schizophrenia
|
|
JPH1160592A
|
|
Cholestanol compound and medicine containing the same
|
|
JPH1132796A
|
|
Assay of glycosyltransferase activity
|
|
JPH1132797A
|
|
Diagnostic for hepatopathy
|
|
JPH10273495A
|
|
Derivatives of gallic acid ester and pharmaceuticals using the same as active ingredient
|
|
JPH1029947A
|
|
Remedy for vivotoxin-type intestinal canal bacterial infection
|
|
JPH09278791A
|
|
Cholestanol compound and production of the same
|
|
JPH08136538A
|
|
Method for predicting effect of interferon treatment for hepatitis c
|
|
JPH07128333A
|
|
Immunoassay for cholesterol ester transfer protein
|
|
JPH06138122A
|
|
Method for measuring chlesterylester transfer protein
|
|
JPH06109729A
|
|
Apoptosis detecting reagent
|
